Instituto De Investigacion En Ciencias De La Salud Germans Trias I Pujol
- Address
- Carretera De Can Ruti, 08916 Barcelona, Spain
Instituto De Investigacion En Ciencias De La Salud Germans Trias I Pujol
The Instituto De Investigacion En Ciencias De La Salud Germans Trias I Pujol is a multidisciplinary research center conducting clinical trials across diverse therapeutic areas, with particular emphasis on oncology, immunology, infectious diseases, and hematology. The institute demonstrates expertise in evaluating novel therapeutic agents and treatment optimization strategies for complex medical conditions requiring specialized care.
- Cutaneous squamous cell carcinoma adjuvant immunotherapy with cemiplimab
- Severe allergic asthma management and omalizumab dose optimization
- Diabetic foot infections treatment with novel antibiotics
- Essential thrombocythemia and myeloproliferative neoplasms
The center's research portfolio reflects a commitment to advancing personalized medicine through Phase 3 randomized controlled trials that address unmet medical needs. Their work spans from cancer immunotherapy post-surgical intervention to respiratory medicine optimization strategies, demonstrating proficiency in both innovative therapeutic development and refinement of existing treatment protocols. The institute's focus on conditions such as diabetic complications and blood disorders underscores their comprehensive approach to improving patient outcomes across multiple medical specialties.
Site Overview
Activity Indicator
Last 6 months
Trial Flow
How this site's trials are distributed across therapeutic areas and active substances (IMPs), and how they're positioned within their overall lifecycle status. Flow thickness represents the number of unique trials.
Top 5 of 7 therapeutic areas and 10 IMPs, ranked by number of trials.
Compounds & Molecules Timeline
The time span of clinical-trial activity for the main active substances (IMPs) studied at this site over the last 8 years. Each bar runs from the earliest trial start to the most recent end; a substance with a trial still open has no recorded end and is shown as ongoing.
Sponsor & Partnership
Top sponsors by active trials, and the ones that have come back for more than one study.
Sponsor Network
Top 3 by active trials.
lock +2 more on a paid plan
Partnership History
Sponsors with repeated collaboration (≥ 2 trials).
No repeated partnerships found.
Sponsor Network Graph
How sponsors and therapeutic areas connect across this site's active trials: each link is at least one active trial shared between them, and bigger nodes mean more activity. Click a node to see its exact connections.
Country Benchmark
Compared to 567 other sites in Spain
Therapeutic Area Benchmark — Spain
Select a therapeutic area to compare against other sites in Spain.
Competitor Comparison
Similar sites in the same country running a comparable number of trials (within ±30%), scored on how closely their trial portfolios match this one. Higher percentages mean a more similar profile.
Country: Spain
Market Share
Country: Spain
Therapeutic Area Market Share
Select a therapeutic area to view its disease coverage breakdown.
Heat Maps & Advanced Analytics
How often specific conditions appear in trials across this site and comparable sites from the same country. Each row is a site, each column a condition, and each cell the number of trials on it — darker means more activity.
Other Trials in Instituto De Investigacion En Ciencias De La Salud Germans Trias I Pujol
lock Showing 1 of 5 trials — the rest is available on a paid plan.
| Trial | Sponsor | Phase | Status | Start Date | End Date |
|---|---|---|---|---|---|
| A Phase 3, Multicenter, Randomized, Double-Blind Study to Evaluate the Safety and Efficacy of Contezolid Acefosamil and Contezolid Compared to Linezolid Administered Intravenously and Orally to Adults with Moderate or Severe Diabetic Foot Infections | Micurx Pharmaceuticals Inc. | Phase III | Recruiting | Mar 2023 | — |
IMP list
lock Showing 1 of 10 compounds — the rest is available on a paid plan.
| IMP | Trials | Status | First start | Last start |
|---|---|---|---|---|
| Aztreonam | 1 | Unknown | 2023-03-17 | 2023-03-17 |
Request feasibility information
Ask this centre about capacity, equipment and patient population.
Upgrade this site to Business Plan
Own the profile, publish your feasibility data and reach sponsors directly.
Is something out of date?
Tell us what needs correcting and we'll update this profile.
lock Available to Business plan sites only.